Axitinib is a targeted therapy drug that is also known as Inlyta®. It is used to treat kidney cancer that has spread outside the kidney (advanced kidney cancer). It can also be given before surgery to remove the kidney in a clinical trial to see if it helps to reduce the cancer. It is best to read this information with our general information about kidney cancer.
Your doctor will talk to you about this treatment and its possible side effects before you agree (consent) to have treatment.
During treatment, you will see a cancer doctor or nurse. This is who we mean when we mention a doctor or nurse in this information.